Clinical Trials Insight: 700043367

Trial Profile

Clinical Trials Insight: 700043367

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Adomiparin (Primary)
  • Indications Acute coronary syndromes
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Momenta Pharmaceuticals
  • Most Recent Events

    • 20 Mar 2009 Results have been published in the proceedings of the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top